Cargando…
Clinical significance of the ‘not otherwise specified’ subtype in candidates for resectable non-small cell lung cancer
The histological subtype of non-small-cell lung cancer (NSCLC) is a significant factor when selecting treatment strategies. However, cases are occasionally encountered that are diagnosed as ‘not otherwise specified’ (NOS) prior to surgery, due to an uncertain histological subtype. The present study...
Autores principales: | TANE, SHINYA, NISHIO, WATARU, OGAWA, HIROYUKI, HOKKA, DAISUKE, TANE, KENTA, TANAKA, YUGO, TAUCHI, SHUNSUKE, UCHINO, KAZUYA, SAKAI, YASUHIRO, OHBAYASHI, CHIHO, YOSHIMURA, MASAHIRO, MANIWA, YOSHIMASA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114594/ https://www.ncbi.nlm.nih.gov/pubmed/25120650 http://dx.doi.org/10.3892/ol.2014.2302 |
Ejemplares similares
-
Significant role of Psf3 expression in non‐small‐cell lung cancer
por: Tane, Shinya, et al.
Publicado: (2015) -
Pulmonary large cell neuroendocrine carcinoma exhibiting extensive pagetoid spread in the bronchial epithelium: A case report
por: OGAWA, HIROYUKI, et al.
Publicado: (2014) -
Programmed death ligand‐1 expression and occult lymph node metastasis in non‐small cell lung cancer
por: Mitsui, Suguru, et al.
Publicado: (2023) -
Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma
por: Kimura, Kenji, et al.
Publicado: (2019) -
Sirt1 is a tumor promoter in lung adenocarcinoma
por: CHEN, XUE, et al.
Publicado: (2014)